The value of quantitative analysis of blood perfusion in the arterial phase of contrast-enhanced ultrasound in the differential diagnosis for focal nodular hyperplasia and hepatocellular carcinoma

ZHOU Jian-hua,HAN Feng,LI An-hua,LIU Long-zhong,CHEN Fang
DOI: https://doi.org/10.3969/j.issn.1672-6448.2009.01.008
2009-01-01
Abstract:Objective To evaluate the value of quantitative analysis for blood perfusion in arterial phase of contrast-enhanced ultrasound in the differential diagnosis of focal nodular hyperplasia(FNH) and hepatocellular carcinoma(HCC).Methods Each subject was administrated with a bolus injection of the ultrasound microbubble agent SonoVue(2.4 ml) into an arm vein.The seventeen patients with diagnosed FNH(FNH group) and 41 patients with diagnosed HCC(HCC group) were analysed with indexes of blood perfusion.The arrival time(AT),time to peak(TTP) and peak intensity(PI) of the liver lesions were measured by time-intensity-curve software.The enhancement time(ET) and ascending slope(AS) were calculated with these parameters.Results(1) AT:FNH group:10.44±1.43 s,HCC group:12.64± 2.30 s;(2) TTP:FNH group:16.64±2.75 s,HCC group:21.32±3.86 s;(3) ET:FNH group:6.19± 1.79 s,HCC group:8.67±2.62 s;(4) AS:FNH group:5.48± 1.71 dB/s,HCC group:3.79±0.99 dB/s.All parameters showed statistical significance between FNH and HCC groups(P <0.001);(5) PI:FNH group:31.42± 3.15 dB,HCC group 30.73±3.86 dB;No difference was observed between two groups(P > 0.05).Conclusions The quantitative analysis of blood perfusion in arterial phase of contrast-enhanced ultrasound can be benefit for the differential diagnosis of FNH and HCC.
What problem does this paper attempt to address?